{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:02:35Z","timestamp":1790863355645,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Osteosarcoma (OS) is the most common primary malignant bone tumor in children and young adults and remains associated with poor clinical outcomes due to recurrence, metastasis, and resistance to conventional chemotherapy. In recent years, copper-based compounds have emerged as promising anticancer agents because of their unique redox properties and ability to target multiple cellular pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this work, we synthesized and characterized two hydrazone ligands, (\n                      <jats:italic>E<\/jats:italic>\n                      )-\n                      <jats:italic>N<\/jats:italic>\n                      \u2032-(2-hydroxybenzylidene)furan-2-carbohydrazide (L1) and (\n                      <jats:italic>E<\/jats:italic>\n                      )-\n                      <jats:italic>N<\/jats:italic>\n                      \u2032-(2-hydroxybenzylidene)-4-methoxybenzohydrazide (L2), together with their corresponding Cu(II) complexes, CuL1 and Cu\n                      <jats:sub>2<\/jats:sub>\n                      L2\n                      <jats:sub>2<\/jats:sub>\n                      . The compounds were characterized by elemental analysis, spectroscopic techniques, high-resolution mass spectrometry, and single-crystal X-ray diffraction. The biological activity of the complexes was evaluated in human MG-63 osteosarcoma cells using the MTT assay. Reactive oxygen species (ROS) generation was assessed using dihydrorhodamine 123 (DHR123) after 24 h of treatment to gain insight into their mechanism of action. Their activity was further evaluated in 3D MG-63 osteosarcoma spheroids using a resazurin-based viability assay, while anti-migratory effects were assessed using the spheroid spreading assay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Biological evaluation demonstrated that coordination to Cu(II) converted the inactive hydrazone ligands into highly potent anticancer agents. Both Cu(II) complexes exhibited potent cytotoxic activity in 2D cell cultures, with IC\n                      <jats:sub>50<\/jats:sub>\n                      values in the low micromolar range and significantly higher activity than cisplatin, whereas the free ligands showed no significant antiproliferative effect. Furthermore, treatment with CuL1 and Cu\n                      <jats:sub>2<\/jats:sub>\n                      L2\n                      <jats:sub>2<\/jats:sub>\n                      induced a rapid increase in intracellular ROS, suggesting that oxidative stress contributes to their mechanism of action. The antitumor potential of the complexes was further assessed using multicellular tumor spheroids, where both compounds reduced spheroid viability, altered spheroid morphology, and significantly inhibited spheroid-derived cell migration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Among the compounds studied, the binuclear complex Cu\n                      <jats:sub>2<\/jats:sub>\n                      L2\n                      <jats:sub>2<\/jats:sub>\n                      displayed the highest antiproliferative activity in both 2D and 3D models. Overall, our findings demonstrate that coordination of hydrazone ligands to Cu(II) markedly enhances their biological activity and identify CuL1 and particularly the binuclear complex Cu\n                      <jats:sub>2<\/jats:sub>\n                      L2\n                      <jats:sub>2<\/jats:sub>\n                      as promising candidates for the development of new copper-based therapeutics against osteosarcoma.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fchem.2026.1897476","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:30:00Z","timestamp":1790861400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of novel Copper(II)\u2013hydrazone complexes for targeting the inhibition of human osteosarcoma growth"],"prefix":"10.3389","volume":"14","author":[{"given":"Luc\u00eda","family":"Santa Maria de la Parra","sequence":"first","affiliation":[{"name":"Departamento de Qu\u00edmica, Facultad de Ciencias Exactas, CEQUINOR (UNLP, CCT-CONICET La Plata, asociado a CIC), Universidad Nacional de La Plata","place":["La Plata, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Espindola-Moreno","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Facultad de Ciencias Exactas, CEQUINOR (UNLP, CCT-CONICET La Plata, asociado a CIC), Universidad Nacional de La Plata","place":["La Plata, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas H.","family":"Assandri","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biol\u00f3gicas, C\u00e1tedra de Microbiolog\u00eda, Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP)","place":["La Plata, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo A.","family":"Echeverr\u00eda","sequence":"additional","affiliation":[{"name":"Departamento de F\u00edsica, Facultad de Ciencias Exactas, Universidad Nacional de La Plata","place":["La Plata, Argentina"]},{"name":"Instituto IFLP (CONICET, CCT-La Plata), Universidad Nacional de La Plata","place":["La Plata, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar E.","family":"Piro","sequence":"additional","affiliation":[{"name":"Departamento de F\u00edsica, Facultad de Ciencias Exactas, Universidad Nacional de La Plata","place":["La Plata, Argentina"]},{"name":"Instituto IFLP (CONICET, CCT-La Plata), Universidad Nacional de La Plata","place":["La Plata, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Scalese","sequence":"additional","affiliation":[{"name":"Departamento Estrella Campos, \u00c1rea Qu\u00edmica Inorg\u00e1nica, Facultad de Qu\u00edmica, Universidad de la Rep\u00fablica","place":["Montevideo, Uruguay"]},{"name":"Laboratory Redox Biology of Trypanosomes, Institut Pasteur de Montevideo","place":["Montevideo, Uruguay"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio E.","family":"Le\u00f3n","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Facultad de Ciencias Exactas, CEQUINOR (UNLP, CCT-CONICET La Plata, asociado a CIC), Universidad Nacional de La Plata","place":["La Plata, Argentina"]},{"name":"Departamento de Ciencias Biol\u00f3gicas, C\u00e1tedra de Fisiopatolog\u00eda, Facultad de Ciencias Exactas, Universidad Nacional de La Plata","place":["La Plata, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1103\/PhysRev.79.350","article-title":"Antiferromagnetism. Theory of superexchange interaction","volume":"79","author":"Anderson","year":"1950","journal-title":"Phys. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1259\/bjr\/54004230","article-title":"Resazurin assay of radiation response in cultured cells","volume":"78","author":"Anoopkumar-Dukie","year":"2005","journal-title":"Br. J. Radiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9812","DOI":"10.1039\/d1dt00869b","article-title":"Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models","volume":"50","author":"Balsa","year":"2021","journal-title":"Dalton Trans."},{"key":"B4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2174\/0929867328666211117094550","article-title":"Copper Complexes as Antitumor Agents: in vitro and in vivo Evidence","volume":"30","author":"Balsa","year":"","journal-title":"Curr. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.3390\/ijms24087531","article-title":"Finding new molecular targets of two Copper(II)-Hydrazone complexes on triple-negative breast cancer cells using mass-spectrometry-based quantitative proteomics","volume":"24","author":"Balsa","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1039\/d3dt02964f","article-title":"New copper(ii) and oxidovanadium(iv) complexes with a vitamin B6 Schiff base: mechanism of action and synergy studies on 2D and 3D human osteosarcoma cell models","volume":"53","author":"Balsa","year":"","journal-title":"Dalton Trans."},{"key":"B7","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.1016\/j.cbi.2023.110685","article-title":"Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: mechanism of action studies over in vitro and in vivo models","volume":"384","author":"Balsa","year":"","journal-title":"Chem. Biol. Interact."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e202400373","DOI":"10.1002\/cbic.202400373","article-title":"Deciphering the effect of a Cu(II)\u2010hydrazone complex on intracellular cell signalling pathways in a human osteosarcoma 2D and 3D models","volume":"25","author":"Balsa","year":"2024","journal-title":"ChemBioChem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104522","DOI":"10.1016\/j.drudis.2025.104522","article-title":"Advances in copper complexes in cancer treatment","volume":"30","author":"Balsa","year":"2025","journal-title":"Drug Discov. Today"},{"key":"B10","doi-asserted-by":"publisher","first-page":"o2015","DOI":"10.1107\/S1600536810024839","article-title":"(E)-N\u2032-(2-Hydroxybenzylidene)furan-2-carbohydrazide","volume":"66","author":"Bikas","year":"2010","journal-title":"Acta Crystallogr. Sect. E Struct. Rep. Online"},{"key":"B11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"113089","DOI":"10.1016\/j.jinorgbio.2025.113089","article-title":"New Cu complexes containing methyl-phenanthroline and dipeptides as cytotoxic agents. Synthesis, characterization and in vitro studies","volume":"274","author":"Brooks","year":"2026","journal-title":"J. Inorg. Biochem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ica.2018.11.039","article-title":"Synthesis, crystal structure and cytotoxicity assays of a copper(II) nitrate complex with a tridentate ONO acylhydrazone ligand. Spectroscopic and theoretical studies of the complex and its ligand","volume":"487","author":"Burgos-Lopez","year":"2019","journal-title":"Inorganica Chim. Acta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"115621","DOI":"10.1016\/j.poly.2021.115621","article-title":"Tridentate acylhydrazone copper(II) complexes with heterocyclic bases as coligands. Synthesis, spectroscopic studies, crystal structure and cytotoxicity assays","volume":"213","author":"Burgos-L\u00f3pez","year":"2022","journal-title":"Polyhedron."},{"key":"B15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2174\/1871520616666160513130204","article-title":"Copper(II) complexes with saccharinate and glutamine as Antitumor agents: Cyto- and genotoxicity in human osteosarcoma cells","volume":"17","author":"Cadavid-Vargas","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1021\/acs.inorgchem.1c03658","article-title":"Cu(I) and Cu(II) complexes based on Lonidamine-Conjugated ligands designed to promote synergistic Antitumor effects","volume":"61","author":"Del Bello","year":"2022","journal-title":"Inorg. Chem."},{"key":"B17","first-page":"469","article-title":"Metallo-Drugs: Development and action of anticancer agents","author":"Denoyer","year":"2018"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1128\/MCB.24.7.2875-2889.2004","article-title":"Hypoxia-Mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-Dependent and -Independent mechanisms and contributes to drug resistance","volume":"24","author":"Erler","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1039\/D4DT03445G","article-title":"Antiproliferative activity of a series of copper(II) complexes derived from a furan-containing N-acylhydrazone: monomers, dimers, charge status, and cell mechanistic studies on triple negative breast cancer cells","volume":"54","author":"Espindola-Moreno","year":"2025","journal-title":"Dalton Trans."},{"key":"B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J. Appl. Crystallogr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"112700","DOI":"10.1016\/j.jinorgbio.2024.112700","article-title":"Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer","volume":"260","author":"Fern\u00e1ndez","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.saa.2014.08.095","article-title":"Structural, spectroscopic and DFT study of 4-methoxybenzohydrazide schiff bases. A new series of polyfunctional ligands","volume":"137","author":"Ferraresi-Curotto","year":"2015","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/inorganics10040047","article-title":"An overview of vanadium and cell signaling in potential cancer treatments","volume":"10","author":"Ferretti","year":"2022","journal-title":"Inorganics (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12873","DOI":"10.1002\/anie.201607216","article-title":"Copper\u2010Catalyzed oxidation of alkanes with H2O2 under a fenton\u2010like regime","volume":"55","author":"Garcia\u2010Bosch","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"B26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1103\/PhysRev.100.564","article-title":"Theory of the role of covalence in the perovskite-type manganites [La, M(II)]MnO3","volume":"100","author":"Goodenough","year":"1955","journal-title":"Phys. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0022-3697(58)90107-0","article-title":"An interpretation of the magnetic properties of the perovskite-type mixed crystals La1\u2212xSrxCoO3\u2212\u03bb","volume":"6","author":"Goodenough","year":"1958","journal-title":"J. Phys. Chem. Solids"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1089\/ars.2010.3663","article-title":"Anticancer activity of metal complexes: involvement of Redox processes","volume":"15","author":"Jungwirth","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0022-3697(59)90061-7","article-title":"Superexchange interaction and symmetry properties of electron orbitals","volume":"10","author":"Kanamori","year":"1959","journal-title":"J. Phys. Chem. Solids"},{"key":"B30","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/cells8050470","article-title":"Application of cancer organoid model for drug screening and personalized therapy","volume":"8","author":"Kondo","year":"2019","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0891-5849(94)90138-4","article-title":"Peroxynitrite-mediated oxidation of dihydrorhodamine 123","volume":"16","author":"Kooy","year":"1994","journal-title":"Free Radic. Biol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mrrev.2012.08.001","article-title":"In vitro cell migration and invasion assays","volume":"752","author":"Kramer","year":"2013","journal-title":"Mutat. Research\/Reviews Mutat. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium complexes as anticancer agents: a brief history and perspectives","volume":"14","author":"Lee","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/17568919.2024.2383166","article-title":"Transition metal complexes: a new generation of anticancer drugs","volume":"16","author":"Le\u00f3n","year":"2024","journal-title":"Future Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00775-016-1397-0","article-title":"In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice","volume":"21","author":"Le\u00f3n","year":"2016","journal-title":"J. Biol. Inorg. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1039\/d1qi00233c","article-title":"Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug","volume":"8","author":"Lev\u00edn","year":"2021","journal-title":"Inorg. Chem. Front."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1007\/s00432-023-04614-4","article-title":"Targeted therapy for osteosarcoma: a review","volume":"149","author":"Li","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.3390\/ijms24086949","article-title":"Applications and advances of multicellular tumor spheroids: challenges in their development and analysis","volume":"24","author":"Mitrakas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e26533","DOI":"10.1002\/pbc.26533","article-title":"Childhood osteosarcoma: incidence and survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000\u20132013","volume":"64","author":"Moreno","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"B42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cellbi.2007.08.028","article-title":"Dihydrorhodamine 123 is superior to 2,7\u2010dichlorodihydrofluorescein diacetate and dihydrorhodamine 6G in detecting intracellular hydrogen peroxide in tumor cells","volume":"32","author":"Qin","year":"2008","journal-title":"Cell Biol. Int."},{"key":"B43","volume-title":"Rigaku. Crysalispro 1.171.38.41","year":"2015"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.1039\/c8nj06274a","article-title":"Cu(II) and Zn(II) complexes with a poly-functional ligand derived from: o -vanillin and thiophene. Crystal structure, physicochemical properties, theoretical studies and cytotoxicity assays against human breast cancer cells","volume":"43","author":"Rodr\u00edguez","year":"2019","journal-title":"New J. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/inorganics9020009","article-title":"Synthesis, crystal structure, spectroscopic characterization, DFT calculations and cytotoxicity assays of a new Cu(II) complex with an acylhydrazone ligand derived from thiophene","volume":"9","author":"Rodr\u00edguez","year":"2021","journal-title":"Inorganics (Basel)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"11931","DOI":"10.1039\/D1DT01358K","article-title":"Synergy of DNA intercalation and catalytic activity of a copper complex towards improved polymerase inhibition and cancer cell cytotoxicity","volume":"50","author":"Romo","year":"2021","journal-title":"Dalton Trans."},{"key":"B47","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1039\/c8mt00369f","article-title":"Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer","volume":"11","author":"Ruiz","year":"2019","journal-title":"Metallomics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/pharmaceutics18030372","article-title":"In vitro and in vivo effects of a Copper(II)-Hydrazone complex against human Osteosarcoma","volume":"18","author":"Santa Maria de la Parra","year":"","journal-title":"Pharmaceutics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e202500836","DOI":"10.1002\/cmdc.202500836","article-title":"Exploring the anticancer properties and mode of action of Copper(II)\u2010Furan acylhydrazone on human triple negative breast cancer cells","volume":"21","author":"Santa Maria de la Parra","year":"","journal-title":"ChemMedChem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"104100","DOI":"10.1016\/j.drudis.2024.104100","article-title":"Metallocompounds as anticancer agents against osteosarcoma. Drug Discovery today","volume":"29","author":"Santa Maria de la Parra","year":"","journal-title":"Drug Discov. Today"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1021\/acs.inorgchem.3c04085","article-title":"Promising dual anticancer and antimetastatic action by a Cu(II) complex derived from acylhydrazone on human Osteosarcoma models","volume":"63","author":"Santa Maria de la Parra","year":"","journal-title":"Inorg. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"113243","DOI":"10.1016\/j.jinorgbio.2026.113243","article-title":"Synthesis, crystal structure, spectroscopic characterization, theoretical studies and cytotoxicity assays of novel two acylhydrazones and its Cu(II) complexes","volume":"279","author":"Santa Maria de la Parra","year":"2026","journal-title":"J. Inorg. Biochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","article-title":"Reactive oxygen species in cancer cells: live by the sword, die by the sword","volume":"10","author":"Schumacker","year":"2006","journal-title":"Cancer Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. A"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT\u2013 integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A Found. Adv."},{"key":"B57","doi-asserted-by":"publisher","first-page":"o767","DOI":"10.1107\/S1600536808008088","article-title":"N\u2032-(2-Hydroxybenzylidene)-4-methoxybenzohydrazide","volume":"64","author":"Tang","year":"2008","journal-title":"Acta Crystallogr. Sect. E Struct. Rep. Online"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","article-title":"Free radicals, metals and antioxidants in oxidative stress-induced cancer","volume":"160","author":"Valko","year":"2006","journal-title":"Chem. Biol. Interact."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1897476\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:30:01Z","timestamp":1790861401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1897476\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":58,"alternative-id":["10.3389\/fchem.2026.1897476"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2026.1897476","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1897476"}}